Figures computed from official regulatory filings — .
Statistical track record
FreeWin rates and median returns are available with a free account (5 insiders/month).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Details | |
|---|---|---|---|---|
Loxo Oncology, Inc.Listing unverified | Sell | $20.1M | SEC | |
Syros Pharmaceuticals, Inc.Listing on record | Buy | $5M | SEC | |
Syros Pharmaceuticals, Inc.Listing on record | OtherD (derivative) | — | SEC | |
Syros Pharmaceuticals, Inc.Listing on record | Other | — | SEC | |
AGILE THERAPEUTICS INCListing unverified | Other | — | SEC | |
Loxo Oncology, Inc.Listing unverified | Buy | $5M | SEC | |
T2 Biosystems, Inc.Listing on record | Buy | $3M | SEC | |
Loxo Oncology, Inc.Listing unverified | Buy | $7M | SEC | |
Loxo Oncology, Inc.Listing unverified | Buy | $2.1M | SEC | |
Loxo Oncology, Inc.Listing unverified | Buy | $53.7K | SEC | |
Zeltiq Aesthetics IncListing unverified | Other | — | SEC | |
Zeltiq Aesthetics IncListing unverified | Other | — | SEC | |
Zeltiq Aesthetics IncListing unverified | Other | — | SEC | |
Zeltiq Aesthetics IncListing unverified | Other | — | SEC | |
Zeltiq Aesthetics IncListing unverified | Other | — | SEC | |
Durata Therapeutics, Inc.Listing unverified | Buy | $10M | SEC | |
Durata Therapeutics, Inc.Listing unverified | OtherD (derivative) | — | SEC | |
Durata Therapeutics, Inc.Listing unverified | Other | — | SEC |